Day One Biopharmaceuticals Inc (DAWN) earnings · rev $158.2M
These earnings events as JSON? API free 100/dayDay One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
This DAWN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported DAWN revenue for 2025-12-31 was $158.2M. Net income was -$107.3M. Revenue was up 20.6% from 2024-12-31 to 2025-12-31. DAWN currently screens at market cap $656.8M.
When the next DAWN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 20.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full DAWN research stays on the stock page; the tape stays on the quote page.
DAWN earnings FAQ
What are DAWN's latest revenue and net income?
Latest cached Day One Biopharmaceuticals Inc (DAWN) revenue for Dec 31, 2025 was $158.2M. Net income was -$107.3M. Statements: https://lician.com/financials/dawn
What is DAWN's latest diluted EPS?
Latest cached Day One Biopharmaceuticals Inc (DAWN) diluted EPS for Dec 31, 2025 was -$1.04.
What period does the latest DAWN earnings print cover?
The latest cached Day One Biopharmaceuticals Inc (DAWN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did DAWN revenue change from the prior cached period?
Cached Day One Biopharmaceuticals Inc (DAWN) revenue was up 20.6% from $131.2M (Dec 31, 2024) to $158.2M (Dec 31, 2025). Statements: https://lician.com/financials/dawn
Where are DAWN earnings listed?
Cached earnings facts for Day One Biopharmaceuticals Inc (DAWN) are listed at https://lician.com/earnings/dawn. Statements: https://lician.com/financials/dawn
Not investment advice.